Well if we use the CEO's suggested valuation metric as stated here:
"Next year we plan to produce in excess of $45 million in revenues, which will make Sugarmade one of the premier public companies in the cannabis market sector, but this does not include any revenues from the Sriracha Seasoning Stix, Seasoning Stix or BudLife product lines where there could be significant upside. With revenue multiples for comparable public companies easily exceeding 4X or 5X next year's revenues, we believe it's easy for most to see the value we plan to create. Thus, we believe this deal will be highly accretive and beneficial to current Sugarmade shareholders, our employees and our trading and manufacturing partners," continued Mr. Chan."
So if $45M is just from BizRight, let's run different estimates for the other products and use 4.5 P/S ratio which is midway of the range from the CEO:
Total sales 2019 $50M x 4.5 P/S = .25 share price
Total sales 2019 $55M x 4.5 P/S = .28 share price
Total sales 2019 $60M x 4.5 P/S = .30 share price
The above assumes 900 total shares outstanding, which assumes 650M for the BizRight acquisition, which I believe is correct.
News 
Market Data 
Discover 
AI
